Table 2.
Sham (n = 11) | Ischemic + PBS (n = 5) | Ischemic + CPC (N = 6) | Ischemic + MITO cell (n = 6) | |
---|---|---|---|---|
LVDd (mm) | 3.16 ± 0.37 | 3.47 ± 0.59 | 3.01 ± 0.17 | 3.32 ± 0.15 |
LVDs (mm) | 2.09 ± 0.32 | 2.66 ± 0.50 | 2.12 ± 0.08 | 2.24 ± 0.17 |
FS | 0.34 ± 0.05 | 0.23 ± 0.02 | 0.30 ± 0.17 | 0.33 ± 0.03 |
EF | 0.62 ± 0.1 | 0.48 ± 0.03 | 0.58 ± 0.1 | 0.61 ± 0.03 |
Left ventricular cardiac function was evaluated by measuring LVDd, LVDs and FS by echocardiography 30 days after treatment in each group. LVDd left ventricular end-diastolic diameter, LVDs left ventricular end-systolic diameter, FS fractional shortening, EF ejection fraction.